4RX-12341-16694
5 vaccinations
11 coded responses
67 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 494 / MI
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Pfizer-BioNTech
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
-
2021-04-28
Dose 2 — Pfizer-BioNTech
- 2021-04-28
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-07-28
- 2021-10-27
-
2021-11-02
Dose 3 — Pfizer-BioNTech
- 2021-11-02
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Swollen left axillary lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral, Tenderness — Feeling: GoodFree text: Continual left axillary tenderness, but less swollenMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral, Tenderness — Feeling: GoodFree text: Slightly improving left axillary tenderness and sellingMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Still improving swollen/tender axillary lymphMedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: All goodMedDRA releases: 2024-11 · check-in free text available
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2022-02-01
-
2022-05-02
Dose 4 — Moderna
- 2022-05-02
-
2022-05-03
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-04
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Swollen/painful axillary lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Improving swollen lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Improving swollen axillary nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-05-07
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Improving swollen axillary lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2022-05-08
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-06-06
- 2022-06-13
- 2022-08-01
-
2022-10-19
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-19
-
2022-10-20
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Nausea, Abdominal painAdult check-in
-
2022-10-21
Survey response — days 1–6 daily, dose 5MedDRA: Lymph node pain, Reaction to previous exposure to any vaccine — Feeling: Good · Site: PainFree text: Very mild left axillary lymph pain, nothing like previous injectionsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Survey response — days 1–6 daily, dose 5MedDRA: Lymph node pain — Feeling: GoodFree text: Continued mild left axillary lymph painMedDRA releases: 2024-11 · check-in free text available
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
- 2023-01-18
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | No |
| 4 | 2022-05-02 | Moderna | No |
| 5 | 2022-10-19 | Pfizer-BioNTech | Flu |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen left axillary lymph node
Systemic reaction (other): Continual left axillary tenderness, but less swollen
Systemic reaction (other): Slightly improving left axillary tenderness and selling
Systemic reaction (other): Still improving swollen/tender axillary lymph
Systemic reaction (other): All good
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Swollen/painful axillary lymph node
Systemic reaction (other): Improving swollen lymph node
Systemic reaction (other): Improving swollen axillary node
Systemic reaction (other): Improving swollen axillary lymph node
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Very mild left axillary lymph pain, nothing like previous injections
Systemic reaction (other): Continued mild left axillary lymph pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
| SRO | Reaction to previous exposure to any vaccine | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release